Fork me on GitHub

Peer-review and openness

This is an interesting battle. Big Pharma vs. traditional peer-reviewed publishing.

A judge ruled that peer-reviewed documents requested by Pfizer could not be released by the New England Journal of Medicine (NEJM). Personally I believe peer-review should not be closed, although I am on the fence about the anonymity of reviewers.

Technorati Tags: , ,

This entry was posted in Pharma, Publishing. Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

blog comments powered by Disqus
  • Archives

  • Disclaimer

    All opinions on this blog are my own and do not reflect those of my employers, past or present